RA Capital Management »

Adicet Bio Ord shares owned by RA Capital Management

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.0M 948k 8.42

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Cidara Therapeutics SH (CDTX)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Vaxcyte SH (PCVX)
Sionna Therapeutics SH (SION)
Newamsterdam Pharma Co Nv SH (NAMS)
Tyra Biosciences SH (TYRA)
Wave Life Sciences SH (WVE)
Mineralys Therapeutics SH (MLYS)
Edgewise Therapeutics SH (EWTX)
Septerna SH (SEPN)
Nuvalent Inc-a SH (NUVL)
Disc Medicine SH (IRON)
Janux Therapeutics SH (JANX)

View all positions for RA Capital Management

Top funds holding Adicet Bio Ord

OrbiMed Advisors
RA Capital Management
Franklin Resources
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Two Sigma Investments
ADAR1 Capital Management

View all funds holding Adicet Bio Ord